Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Neutrophils and monocytes encompassing the classical, intermediate and non-classical population constitute the majority of circulating myeloid cells in humans and represent the first line of innate immune defense. As such, changes in their relative and absolute amounts serve as sensitive markers of diverse inflammatory conditions. Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system causing demyelination and axonal loss affecting various neuron functions and often causing irreversible neurological disability. MS disease course is individually highly heterogenous but can be classified as progressive (PMS) or relapsing-remitting (RRMS). Each MS course type may be further characterized as active or inactive, depending on the recent disability progression and/or current relapses. Data on specific alterations of the myeloid compartment in association with MS disease course is scarce and conflicting. In the current study, we systematically immunophenotyped blood myeloid leukocytes by flow cytometry in 15 healthy and 74 MS subjects. We found a highly significant expansion of neutrophils, classical and non-classical monocytes in inactive RRMS (RRMSi), which did not correlate with biochemical readouts of systemic inflammation. Each of these leukocyte populations and the combined myeloid signature accurately differentiated RRMSi from other MS forms. Additionally, non-classical monocyte proportions were particularly elevated in RRMSi individuals receiving disease-modifying therapy (DMT), such as natalizumab. Our results suggest that flow cytometry-based myeloid cell immunophenotyping in MS may help to identify RRMSi earlier and facilitate monitoring of DMT response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167
Defining the clinical course of multiple sclerosis: The 2013 revisions
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000560 · Cited by 3,177
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491 · cited 21×
“For RRMS, a rapidly growing number of disease-modifying therapy (DMT) have proven to reduce number of relapses, brain and spinal MS activity determined by magnetic resonance imaging [MRI; new or enlarging T2 lesions or gadolinium-enhanced (GE) T1 lesions] and, to a lesser extent, delay disability progression, whereas…”
BackgroundMethodInfluentialInfiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061 · cited 1×
“Data from animal models and human MS studies suggest that circulating monocytes and neutrophils act as a source of inflammatory cytokines (10, 12, 24) and participate in axonal destruction (8, 9, 11, 15, 16, 35, 42).”
BackgroundThe fate and lifespan of human monocyte subsets in steady state and systemic inflammation
Patel, A. A., Zhang, Y., Fullerton, J. N., Boelen, L., Rongvaux, A., Maini, A. A., Bigley, V., Flavell, R. A., Gilroy, D. W., Asquith, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170355 · Cited by 946 · cited 1×
“In this context, it is tempting to speculate whether the increased pan-leukocyte frequency of nonclassical monocytes upon natalizumab exposure results from inhibition of the CNS entry of those cells or their precursors, classical and intermediate monocytes (44).”
BackgroundDifferential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Mildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445 · cited 1×
“Data from animal models and human MS studies suggest that circulating monocytes and neutrophils act as a source of inflammatory cytokines (10, 12, 24) and participate in axonal destruction (8, 9, 11, 15, 16, 35, 42).”
BackgroundSeidler, S., Zimmermann, H. W., Bartneck, M., Trautwein, C., & Tacke, F. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-30 · Cited by 390
Liu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., Padovani-Claudio, D., He, T., Choi, K., Lane, T. E., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2491 · Cited by 214
Frailty is associated with elevated CRP trajectories and higher numbers of neutrophils and monocytes
Samson, L. D., Boots, A. M. H., Verschuren, W. M. M., Picavet, H. S. J., Engelfriet, P., & Buisman, A.-M. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110674 · Cited by 77 · cited 1×
“Literature evidence indicates that gender, age, and overall physical status (frailty) may impact on proportions and numbers of circulating myeloid cells including the cell types differentially expanded in RRMSi in our study, like granulocytes (37, 38) and, intermediate and nonclassical monocytes (37– 41).”
BackgroundClassical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes
Haschka, D., Petzer, V., Kocher, F., Tschurtschenthaler, C., Schaefer, B., Seifert, M., Sopper, S., Sonnweber, T., Feistritzer, C., Arvedson, T. L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.98867 · Cited by 34 · cited 1×
“1mM of Na2EDTA), and antibody stained essentially as described (31, 51).”
BackgroundSelf-citation
Cited by
Jagadeesh, K. A., Dey, K. K., Montoro, D. T., Mohan, R., Gazal, S., Engreitz, J. M., Xavier, R. J., Price, A. L., & Regev, A. (2022) · Nature Genetics · doi:10.1038/s41588-022-01187-9 · Cited by 239
Disorders of the enteric nervous system — a holistic view
Niesler, B., Kuerten, S., Demir, I. E., & Schäfer, K.-H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00385-2 · Cited by 196
Inflammation in multiple sclerosis
Haase, S., & Linker, R. A. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211007687 · Cited by 183
Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases
Meldolesi, J. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00040-5 · Cited by 47
CNS macrophage contributions to myelin health
Hoffmann, A., & Miron, V. E. (2024) · Immunological Reviews · doi:10.1111/imr.13416 · Cited by 13
Metadata
- Authors
- Haschka, D., Tymoszuk, P., Bsteh, G., Petzer, V., Berek, K., Theurl, I., Berger, T., & Weiss, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-29
- Volume
- 11
- Pages
- 594-594
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3022089954
- Cited by
- 60
- References
- 11
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.